Why hair loss is a biotech challenge

Written by Alena Weissenbaeck, Founder of WELAB BIOTECH and Hair Practitioner (IAT).

Before launching WELAB BIOTECH, I decided to approach this topic as a science problem, not a beauty trend.
And the deeper I go into trichology, the clearer it becomes: Hair loss isn’t a cosmetic issue. It’s a biological process, complex, multifactorial and often misunderstood.

Hair loss is often discussed as though it were one problem with one solution.

Find the right ingredient. Apply it to the scalp. Wait for the hair to return.

The biology is considerably more complex.

Hair density can change through different processes involving the growth cycle, genetic and hormonal sensitivity, cellular signalling, inflammation, general health and the condition of the scalp. These factors do not affect every person or every follicle in the same way.

This is why hair loss is not merely a cosmetic formulation problem. It is a biological system involving multiple interacting pathways.

It is also why the presence of one fashionable ingredient does not automatically make a product effective.

Hair Loss Is Not One Biological Process

“Hair loss” is an umbrella term rather than a diagnosis.

A person noticing increased shedding may be experiencing a temporary change in the hair cycle. Another may have progressive follicular miniaturisation. Others may have an inflammatory, autoimmune, nutritional, hormonal or medication-related condition.

These processes can look similar to the untrained eye but may require very different approaches.

Cosmetic scalp care may help support scalp condition and improve the appearance of thinning hair. It cannot determine why hair loss is happening, treat every form of alopecia or replace appropriate medical assessment.

Before choosing a solution, it is important to recognise that different types of hair loss do not share one universal mechanism.

The Hair Follicle Is a Dynamic Mini-Organ

The hair follicle is not simply a pore holding a strand of hair.

It is a dynamic structure containing epithelial and mesenchymal cells, stem-cell populations, connective tissue, blood vessels, immune components and a sebaceous gland. These elements communicate throughout the hair cycle.

Each follicle repeatedly moves through several phases:

Anagen: the active growth phase during which the hair fibre is produced;
Catagen: a short regression phase;
Telogen: a resting phase;
Exogen: release of the existing hair fibre.

A visible hair is therefore the end product of coordinated biological activity taking place beneath the scalp.

At the base of the follicle is the dermal papilla, a specialised population of cells involved in regulating growth and communicating with surrounding follicular cells.

Changes in dermal papilla activity can influence the signals received by the cells that produce the hair fibre. The behaviour and signalling capacity of this structure are therefore relevant to the calibre and growth of the resulting hair.

Why Hair Thinning Involves Multiple Pathways

The biology of thinning hair cannot be reduced to a single switch.

Several pathways may contribute, and their relative importance varies between individuals.

1. Hair-Cycle Regulation

Visible density depends partly on how many follicles are actively producing hair and how long they remain in the growth phase.

When a greater proportion of follicles shifts into a resting or shedding phase, shedding can increase even without permanent destruction of the follicle.

In progressive pattern hair loss, repeated cycles may also produce increasingly finer and shorter hairs. This process is known as follicular miniaturisation.

Supporting the appearance of fuller hair is therefore not only about stimulating “growth.” It also involves considering hair-cycle balance, retention and the quality of the fibre produced during each cycle.

2. Hormonal Sensitivity

Androgens do not affect all human hair follicles in the same way.

They can encourage terminal hair growth in some body regions while contributing to progressive miniaturisation in genetically susceptible scalp follicles.

Research has found higher androgen-receptor levels in dermal papilla cells obtained from balding scalp follicles compared with cells from non-balding scalp. This supports the idea that local follicular sensitivity—not simply the amount of circulating hormone—is relevant to androgenetic alopecia.¹

Laboratory research has also shown that androgen exposure can change signalling from balding dermal papilla cells, including the secretion of TGF-β1, which affected the growth of neighbouring epithelial cells in the experimental model.²

The process is therefore more complex than “too much DHT.” It involves the way a susceptible follicle receives and translates hormonal signals.

3. Local Signalling Molecules

Hormones are not the only local signals capable of affecting follicular behaviour.

A study of scalp tissue from men with androgenetic alopecia found increased levels of prostaglandin D2 in balding areas. The researchers also found that PGD2 inhibited hair growth in experimental human-follicle and animal models.³

This does not mean that prostaglandin D2 explains every case of hair loss. It demonstrates something broader:

The follicle is regulated by a network of local signals, not by one isolated mechanism.

Growth factors, prostaglandins, cytokines, Wnt-related signals and extracellular-matrix interactions are all areas of continuing hair research.

4. Cellular Stress and Senescence

Cells do not maintain identical function throughout life.

Oxidative stress, accumulated cellular damage and senescence may affect the ability of follicular cells to communicate and support repeated growth cycles.

Researchers comparing dermal papilla cells from balding and non-balding scalp observed signs of premature senescence in cells obtained from balding follicles.⁴

Subsequent laboratory work found that androgen-receptor signalling could accelerate markers of premature senescence and DNA damage in human dermal papilla cells.⁵

These findings do not prove that an antioxidant cosmetic can reverse hair loss. They show why the long-term condition and signalling capacity of follicular cells are important areas of scientific research.

For a broader discussion of ageing, scalp maintenance and the long-term quality of the hair fibre, read our guide to hair longevity and how hair changes over time.

5. Perifollicular Inflammation and the Scalp Environment

The follicle exists within the skin, not separately from it.

Histological research has observed inflammatory cells and progressive tissue changes around follicles in some samples affected by pattern alopecia.⁶

However, inflammation should not be treated as a universal explanation for every case of thinning hair.

It is also important to distinguish between:

diagnosed inflammatory scalp disease;
histological inflammation that cannot be confirmed without examination;
ordinary cosmetic sensitivity, dryness or discomfort.

A cosmetic product should not claim to treat pathological inflammation. It can be designed to minimise unnecessary irritation and support hydration, barrier comfort and a balanced scalp environment.

Persistent redness, burning, pain, heavy scaling, pustules or scarring require professional assessment rather than increasingly aggressive cosmetic treatment.

Why One Hero Ingredient Is Rarely the Whole Answer

The hair-care industry often builds products around one recognisable active.

Caffeine. Rosemary. A peptide. A botanical extract. A new biotechnology ingredient.

A single ingredient may have interesting laboratory, supplier or clinical data. But the ingredient name alone does not tell us how the finished product will perform.

Its practical value depends on factors including:

the concentration used;
the quality and specification of the raw material;
solubility within the formula;
stability throughout the product’s shelf life;
compatibility with other ingredients;
the delivery vehicle;
contact with the scalp;
tolerability during repeated use;
consistent application by the user.

A formula containing a long list of trend-driven ingredients is not necessarily more advanced than a focused formula. Equally, a higher percentage is not automatically better if it compromises stability, texture or scalp tolerance.

This is why WELAB follows a formulation-first rather than ingredient-first approach.

We explore this principle in more detail in Why Most Hair Growth Products Focus on the Wrong Things.

Not Every Ingredient Needs to “Reach the Follicle”

It is tempting to judge every scalp ingredient by whether it penetrates deeply enough to reach the follicular bulb.

That is an oversimplification.

Some ingredients are selected to support hydration, barrier condition and scalp comfort at or near the surface. Others are intended to interact with structures or pathways closer to the follicular opening. The appropriate delivery requirement depends on the ingredient and its intended cosmetic function.

For a leave-on scalp formula, important considerations include:

even distribution across the target area;
sufficient contact time;
ingredient stability;
a vehicle suitable for the selected actives;
a texture that does not discourage daily use.

Penetration is only one part of formulation performance. More penetration is not always better, and a penetration-supporting ingredient does not turn a cosmetic into a medicinal treatment.

What Cosmetic Scalp Care Can and Cannot Do

A cosmetic scalp serum can be designed to:

support scalp hydration and comfort;
help maintain a balanced scalp environment;
help reduce the appearance of excessive shedding;
support stronger-feeling hair;
improve the appearance of density and thickness;
complement a consistent, long-term hair-care routine.

It cannot responsibly promise to:

treat every type of alopecia;
correct a thyroid, iron or hormonal disorder;
regenerate a follicle destroyed by scarring;
override genetic susceptibility;
guarantee new hair growth in every user;
replace evidence-based medical treatment.

Clear limitations do not make a product weak. They make its positioning credible.

The WELAB Multi-Pathway Formulation Approach

The WELAB BIOTECH Advanced Multi-Peptide Scalp Serum was developed around the idea that thinning hair and scalp condition involve more than one cosmetic objective.

Rather than relying on a single hero active, the formula combines complementary ingredient systems.

The ingredients were selected to support different aspects of the formula’s intended cosmetic performance from scalp condition and resilience to visible shedding and the appearance of density and thickness.

This does not mean that the serum treats every biological process described in this article. Research on individual ingredients should also not be confused with evidence obtained from testing the complete finished formulation.

You can review the ingredient logic and supporting research on the WELAB BIOTECH Science page.

The formulation is designed for once-daily application because biological timelines are slow and consistency matters. A sophisticated formula that is sticky, irritating or difficult to apply is unlikely to become a reliable long-term routine.

Learn more about the relationship between formulation, texture and daily adherence in Where Science Becomes Strength.

From Hair-Loss Intervention to Hair Longevity

Hair-loss care often begins only after visible density has already changed.

Hair longevity introduces a broader and more preventive question:

How can we preserve the best realistic conditions for the scalp, follicle and existing hair fibre over time?

The two concepts are connected but not identical.

Hair-loss research examines the mechanisms behind shedding, miniaturisation and follicular dysfunction. Hair longevity also considers biological ageing, fibre damage, scalp maintenance, early observation and long-term resilience.

Neither concept supports miracle claims. Both point towards the same practical conclusion: meaningful hair care requires patience, consistency and an understanding of biological limitations.

Read the full guide: Hair Longevity: What It Means and How to Support Hair as You Age.

When Hair Loss Needs Professional Assessment

Cosmetic care should not delay diagnosis.

Consult a dermatologist or another appropriately qualified healthcare professional when hair loss is:

sudden or rapidly progressive;
patchy or asymmetrical;
accompanied by pain, burning, marked redness or heavy scaling;
associated with broken hairs, pustules or scarring;
affecting the eyebrows or eyelashes;
occurring alongside other unexplained physical symptoms;
continuing after illness, childbirth or another major physiological stressor;
causing significant concern despite a consistent routine.

Photographing the same parting and scalp areas under similar lighting can help show whether a visible change is stable or progressing.

The Real Biotech Challenge

The challenge is not to fit the greatest possible number of active ingredients into one bottle.

It is to understand which cosmetic objectives can reasonably be addressed, select ingredients with a clear purpose, combine them in a stable and tolerable system, test the finished formulation and communicate the results without exceeding the evidence.

That is the standard WELAB BIOTECH is working towards.

There is no miracle ingredient. No biological shortcuts. A complete formulation designed around the complexity of hair and scalp care.

Explore the WELAB BIOTECH Advanced Multi-Peptide Scalp Serum.

Frequently Asked Questions

Why is hair loss described as multifactorial?

Reduced density can result from different and sometimes overlapping processes, including altered hair cycling, genetic and hormonal sensitivity, illness, nutritional factors, medication, inflammation and ageing. The dominant factor differs between individuals.

Can one ingredient stop hair loss?

No cosmetic ingredient can be expected to address every form or cause of hair loss. An ingredient may support a particular cosmetic objective, but the finished formulation and the underlying cause of thinning both matter.

Does a scalp serum need to penetrate to the follicular bulb?

Not every ingredient has the same intended site of action. Some ingredients support the surface scalp environment, while others are selected for follicle-related cosmetic objectives. Stability, distribution, contact time and tolerability are also relevant to finished-product performance.

How long should a scalp serum be used before evaluating it?

Scalp comfort may change relatively quickly, but hair-cycle-related changes require longer observation. A minimum period of approximately 12 weeks is more meaningful than judging a product after several applications, although visible changes may take several months.

Can a cosmetic serum replace medical hair-loss treatment?

No. Cosmetic scalp care can support appearance and scalp condition but cannot replace diagnosis or prescribed treatment for a medical form of hair loss.

About the Author

Alena Weissenbaeck is the founder of WELAB BIOTECH, an Austrian science-led hair and scalp care company.

She holds a Hair Practitioner Certificate from the International Association of Trichologists (IAT). Her work focuses on hair-follicle biology, scalp care, cosmetic active ingredients and the responsible translation of scientific research into product development.

Her educational articles do not provide medical diagnosis or treatment.

Scientific References

Hibberts NA, Howell AE, Randall VA. Balding hair follicle dermal papilla cells contain higher levels of androgen receptors than those from non-balding scalp. Journal of Endocrinology. 1998. View the study on PubMed.
Inui S, Fukuzato Y, Nakajima T, Yoshikawa K, Itami S. Androgen-inducible TGF-beta1 from balding dermal papilla cells inhibits epithelial cell growth. FASEB Journal. 2002. View the study on PubMed.
Garza LA, et al. Prostaglandin D2 inhibits hair growth and is elevated in bald scalp of men with androgenetic alopecia. Science Translational Medicine. 2012. View the study on PubMed.
Bahta AW, Farjo N, Farjo B, Philpott MP. Premature senescence of balding dermal papilla cells in vitro is associated with p16INK4a expression. Journal of Investigative Dermatology. 2008. View the study on PubMed.
Yang YC, et al. Androgen receptor accelerates premature senescence of human dermal papilla cells in association with DNA damage. PLOS ONE. 2013. View the study on PubMed.
Jaworsky C, Kligman AM, Murphy GF. Characterization of inflammatory infiltrates in male pattern alopecia: implications for pathogenesis. British Journal of Dermatology. 1992. View the study on PubMed.
Matsumura H, et al. Hair follicle aging is driven by transepidermal elimination of stem cells via COL17A1 proteolysis. Science. 2016. View the study on PubMed.

This article is provided for educational purposes and does not replace professional medical diagnosis or treatment.